Previous Article | Next Article 
Journal of Virology, November 1999, p. 9089-9097, Vol. 73, No. 11
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Human Immunodeficiency Virus Type 1-Induced
Hematopoietic Inhibition Is Independent of Productive Infection of
Progenitor Cells In Vivo
Prasad S.
Koka,1
Beth D.
Jamieson,1
David G.
Brooks,2 and
Jerome A.
Zack1,2,*
Division of Hematology/Oncology, Department
of Medicine, Jonsson Comprehensive Cancer Center, UCLA AIDS
Institute,1 and Department of
Microbiology, Immunology and Molecular
Genetics,2 UCLA School of Medicine, Los
Angeles, California 90095
Received 22 March 1999/Accepted 14 July 1999
Human immunodeficiency virus (HIV)-infected individuals exhibit a
variety of hematopoietic dysfunctions. The SCID-hu mouse (severe
combined immunodeficient mouse transplanted with human fetal thymus and
liver tissues) can be used to model the loss of human hematopoietic
precursor cell function following HIV infection and has a distinct
advantage in that data can be obtained in the absence of confounding
factors often seen in infected humans. In this study, we establish that
HIV type 1 (HIV-1) bearing a reporter gene inserted into the viral
vpr gene is highly aggressive in depleting human myeloid
and erythroid colony-forming precursor activity in vivo. Human
CD34+ progenitor cells can be efficiently recovered from
infected implants yet do not express the viral reporter gene, despite
severe functional defects. Our results indicate that HIV-1 infection
alone leads to hematopoietic inhibition in vivo; however, this effect
is due to indirect mechanisms rather than to direct infection of
CD34+ cells in vivo.
*
Corresponding author. Mailing address: Division of
Hematology/Oncology, 11-934 Factor Bldg., 10833 LeConte Ave., UCLA
School of Medicine, Los Angeles, CA 90095-1678. Phone: (310) 794-7765. Fax: (310) 825-6192. E-mail: jzack{at}ucla.edu.
Journal of Virology, November 1999, p. 9089-9097, Vol. 73, No. 11
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Redd, A. D., Avalos, A., Essex, M.
(2007). Infection of hematopoietic progenitor cells by HIV-1 subtype C, and its association with anemia in southern Africa. Blood
110: 3143-3149
[Abstract]
[Full Text]
-
Watanabe, S., Terashima, K., Ohta, S., Horibata, S., Yajima, M., Shiozawa, Y., Dewan, M. Z., Yu, Z., Ito, M., Morio, T., Shimizu, N., Honda, M., Yamamoto, N.
(2007). Hematopoietic stem cell-engrafted NOD/SCID/IL2R{gamma}null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses. Blood
109: 212-218
[Abstract]
[Full Text]
-
Williams, C. A., Mondal, D., Agrawal, K. C.
(2005). The HIV-1 Tat Protein Enhances Megakaryocytic Commitment of K562 Cells by Facilitating CREB Transcription Factor Coactivation by CBP. Exp. Biol. Med.
230: 872-884
[Abstract]
[Full Text]
-
Thiebot, H., Vaslin, B., Derdouch, S., Bertho, J.-M., Mouthon, F., Prost, S., Gras, G., Ducouret, P., Dormont, D., Le Grand, R.
(2005). Impact of bone marrow hematopoiesis failure on T-cell generation during pathogenic simian immunodeficiency virus infection in macaques. Blood
105: 2403-2409
[Abstract]
[Full Text]
-
Koka, P. S., Kitchen, C. M. R., Reddy, S. T.
(2004). Targeting c-Mpl for Revival of Human Immunodeficiency Virus Type 1-Induced Hematopoietic Inhibition When CD34+ Progenitor Cells Are Re-Engrafted into a Fresh Stromal Microenvironment In Vivo. J. Virol.
78: 11385-11392
[Abstract]
[Full Text]
-
Tripp, A., Liu, Y., Sieburg, M., Montalbano, J., Wrzesinski, S., Feuer, G.
(2003). Human T-Cell Leukemia Virus Type 1 Tax Oncoprotein Suppression of Multilineage Hematopoiesis of CD34+ Cells In Vitro. J. Virol.
77: 12152-12164
[Abstract]
[Full Text]
-
Thiebot, H., Louache, F., Vaslin, B., de Revel, T., Neildez, O., Larghero, J., Vainchenker, W., Dormont, D., Le Grand, R.
(2001). Early and Persistent Bone Marrow Hematopoiesis Defect in Simian/Human Immunodeficiency Virus-Infected Macaques despite Efficient Reduction of Viremia by Highly Active Antiretroviral Therapy during Primary Infection. J. Virol.
75: 11594-11602
[Abstract]
[Full Text]
-
Levine, A. M., Scadden, D. T., Zaia, J. A., Krishnan, A.
(2001). Hematologic Aspects of HIV/AIDS. ASH Education Book
2001: 463-478
[Abstract]
[Full Text]